Company / Revenue
cbdMD, Inc. Revenue History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$19.5M
FY2025
5-year range
$19.5M / $44.5M
FY2021-FY2025
Trend
-19.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue has declined for 3 consecutive years, from $44M in FY2022 to $19M in FY2025.
Based on SEC 10-K filings.
$19M in FY2025 with a 5-year CAGR of -3.8%.
Declined from $35M to $19M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- -24.1%
- 5-Year CAGR
- -3.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- cbdMD, Inc.'s revenue has declined for 3 consecutive years.
- 5-year CAGR of -3.8%, indicating a declining trend.
- In FY2025, revenue decreased 19.3% year-over-year.
- Peak revenue was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 1.21 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $19.5M | -19.3% |
| FY2024 | $24.2M | -31.8% |
| FY2023 | $35.4M | -20.4% |
| FY2022 | $44.5M | +6.2% |
| FY2021 | $41.9M | +77.1% |
| FY2020 | $23.7M | +5051.8% |
| FY2019 | $459.1K | -89.7% |
| FY2018 | $4.5M | +120.3% |
| FY2017 | $2.0M | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026